Clinical Trials
2 trialsNCT01083849 2014-12-19
TOP
AbbVie
Completed
NCT01273597 2013-01-18
Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid Glands
AbbVie
Completed